Stay updated on Pembrolizumab Combo vs Placebo in Cervical Cancer Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab Combo vs Placebo in Cervical Cancer Clinical Trial page.

Latest updates to the Pembrolizumab Combo vs Placebo in Cervical Cancer Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoNo Change Detected
- Check18 days agoChange DetectedAdded a new publication citation detailing the final KEYNOTE-826 analysis (Ann Oncol, 2025). Updated the record version to Revision: v3.6.3, replacing the previous v3.6.2.SummaryDifference0.0%

- Check25 days agoChange DetectedThe page revision label updated from v3.6.0 to v3.6.2, indicating a minor update to the page.SummaryDifference0.0%

- Check39 days agoChange DetectedNew help and navigation sections have been added to guide readers (No longer looking for participants, How to Read a Study Record, Common Questions, How to Join a Study) and the page revision updated to v3.6.0. The Intervention/Treatment header formatting was standardized and the older revision tag v3.5.5 removed.SummaryDifference0.2%

- Check46 days agoChange DetectedThe page’s revision tag was updated to v3.5.5, indicating a newer version of the page template or content. No study data or public information appears to be altered.SummaryDifference0.0%

- Check68 days agoChange DetectedPage revision updated from v3.5.3 to v3.5.4, indicating a minor backend/page build change. The visible study details remain unchanged.SummaryDifference0.0%

- Check82 days agoChange DetectedThe Taiwan study location label in the site list has been updated from 'Taoyuan District' to 'Taoyuan', providing a city-level designation for the site. This clarifies the geographic presentation of the site within the study's locations and may affect how participants find and select locations.SummaryDifference0.0%

Stay in the know with updates to Pembrolizumab Combo vs Placebo in Cervical Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Combo vs Placebo in Cervical Cancer Clinical Trial page.